Fig. 7: Fragment analysis of Comirnaty and Spikevax vaccines using DNF-930 dsDNA 930 Reagent Kit. | npj Vaccines

Fig. 7: Fragment analysis of Comirnaty and Spikevax vaccines using DNF-930 dsDNA 930 Reagent Kit.

From: Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no excessive DNA impurities

Fig. 7

Representative electropherograms of FP9632 and 000058A show no specific peaks, indicating the absence of DNA quantities within the detection range of the kit. Two visible peaks correspond to size markers (LM—lower marker of 1 bp, UM—upper marker of 20,000 bp). All other batches exhibited similar profiles of electropherograms (see Supplementary Fig. S8).

Back to article page